Low-cost blood test for early Alzheimer’s disease could bring annual screenings within reach

In a proof-of-concept study by a team that included USC Dornsife researchers Christopher Beam and Margaret Gatz, the inexpensive test detected five key biomarkers of Alzheimer’s disease — more than current commercially available blood tests can measure.